GLOBUS MEDICAL INC - A (GMED:NYSE)
$79.78 -2.1 (-2.5647%)
Analysed GLOBUS MEDICAL INC - A (GMED:NYSE) News Sources
GMED's Robotics Leasing Shift Could Build Recurring Revenue
29-05-2026
yahoo.com
HealthEquity Stock Gains as Q1 Earnings Top Estimates, Revenues Up Y/Y
29-05-2026
yahoo.com
Teladoc Health Broadens Virtual Care Reach Through Walmart Platform
29-05-2026
yahoo.com
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
29-05-2026
yahoo.com
LH Expands Genetic Testing in CRC Through New Collab: Stock to Gain?
01-06-2026
yahoo.com
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
01-06-2026
yahoo.com
Abbott's CE Mark Win for Libre Duo Systems May Lift Its Stock
01-06-2026
yahoo.com
Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Globus Medical (NYSE:GMED) Vs The Rest
01-06-2026
yahoo.com
PacBio Expands HiFi Sequencing Reach With New SPRQ-Nx Technology
01-06-2026
yahoo.com
NTRA & Diakonos Partner to Use Signatera in Refractory Melanoma Trial
01-06-2026
yahoo.com
What is the current price of GLOBUS MEDICAL INC - A (GMED:NYSE)?
The current price of GLOBUS MEDICAL INC - A (GMED:NYSE) is $79.78.
GLOBUS MEDICAL INC - A (GMED:NYSE) absolute price change since previous trading day?
The absolute price change of GLOBUS MEDICAL INC - A (GMED:NYSE) since the previous trading day is $-2.1.
GLOBUS MEDICAL INC - A (GMED:NYSE) percentage price change since previous trading day?
The percentage price change of GLOBUS MEDICAL INC - A (GMED:NYSE) since the previous trading day is -2.5647%.
What is the most recent average sentiment score for GLOBUS MEDICAL INC - A (GMED:NYSE)?
The most recent average sentiment score for GLOBUS MEDICAL INC - A (GMED:NYSE) is 59 out of 100.
What is the most recent average sentiment for GLOBUS MEDICAL INC - A (GMED:NYSE)?
The most recent sentiment for GLOBUS MEDICAL INC - A (GMED:NYSE) is .
SEC-8K** Filing Available For GLOBUS MEDICAL INC - A (GMED:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.